A phase Ib/randomized phase II, non-comparative, open label trial of paclitaxel and carboplatin with or without the anti-IGF-IR antibody CP-751,871 as first-line treatment for advanced non-small cell lung cancer (NSCLC).

Details

Language :

English

ISSN :

15560864

Volume :

2

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

115803985

Full Text :

https://doi.org/10.1097/01.JTO.0000283411.38367.97